Recombinant Staphylococcus aureus vaccine (Chongqing Yuanlun biological technology)

重组金黄色葡萄球菌疫苗（重庆原伦生物）

Report date: 2026/05/15 20:01:45

Base Information

Drug NameRecombinant Staphylococcus aureus vaccine (Chongqing Yuanlun biological technology)
Drug Alias NameN/A
ClassificationVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSurgical Wound InfectionToxemiaStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChengdu Oulin Biological Science & Technology Co LtdArmy Medical University, China
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesArmy Medical University, ChinaChongqing Yuanlun Biotechnology Co Ltd
Inactive CompaniesChengdu Oulin Biological Science & Technology Co Ltd
Active IndicationsSurgical Wound InfectionStaphylococcal Infections
Inactive IndicationsToxemia

Other Information

ATC CodeN/A
Related LinksN/A